AVBP financials
ArriVent BioPharma (AVBP) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
AVBP income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | -$177.53M | -$166.31M | -4.32 |
| 2024 | $0.00 | $0.00 | -$94.31M | -$80.49M | -2.56 |
| 2023 | $0.00 | $0.00 | -$74.59M | -$69.33M | -2.17 |
| 2022 | $0.00 | $0.00 | -$36.91M | -$36.91M | -1.10 |
| 2021 | $0.00 | $0.00 | -$8.70M | -$51.61M | -40.44 |